Clinical Trials Logo
  1. Home
  2. Coxarthrosis
  3. NCT03809962
  4. Details
NCT03809962 Clinical Trial

Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis

Coxarthrosis Clinical Trial

Official title:
Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03809962
Other study ID # OSTH-PMCF-DE-2018-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 30, 2019
Est. completion date August 2024

Study information
Verified date June 2024
Source TRB Chemedica AG
Contact Raphaela Geiger
Phone +49 89 461483-27
Email geiger@trbchemedica.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

PMCF study to observe the Routine application of Ostenil® Plus in the Treatment of pain and restricted mobility in degenerative and traumatic changes of the Hip Joint.

Recruitment information / eligibility
Status Recruiting
Enrollment 250
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: 1. Subjects = 18 years of age and in good general health condition 2. Signed informed consent 3. Existing Ostenil® Plus recommendation for the treatment of coxarthrosis Exclusion Criteria: 1. Known hypersensitivity to one of the OSTENIL® PLUS components 2. Known pregnancy or lactating females 3. Previous/concomitant participation in clinical investigation within the last 3 months prior to study inclusion 4. Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts 5. Subjects unable to understand informed consent or having a high probability of non compliance to the study procedures and / or non completion of the study according to investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Ostenil® Plus
Ostenil® Plus is a CE-certified viscoelastic solution for injection into the Joint cavity, containing 2.0 % Sodium hyaluronate from fermentation

Locations
Country Name City State
Germany Gemeinschaftspraxis für Orthopädie und Unfallchirurgie Bad Oldesloe Schleswig-Holstein
Germany Orthopädische Gemeinschaftspraxis Eutin Eutin
Germany Orthopraxis Kiel Gettorf Schleswig-Holstein
Germany Orthopädische Praxis Rahlstedt Hamburg
Germany Zentrum für Medizin des Bewegungsapparates Heide Schleswig-Holstein
Germany Orthopädie Praxis Ramelsloh
Germany OrthopädieZentrum Maschen Seevetal

Sponsors (1)
Lead Sponsor Collaborator
TRB Chemedica AG

Country where clinical trial is conducted

Germany, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change of Pain Intensity compared to Baseline (VAS-slider) Evaluation of Pain Intensity by the Patient on a 10 cm VAS-slider (10 cm equals the most pain) Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Change of Range of Motion compared to Baseline (Goniometer measurement) Assessment of the Range of internal and exernal rotation of the Hip Joint using a Goniometer. Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Change of Subjective Symptom Evaluation (Overall Impression on a scale from 1 to 5) The Change of Overall Subjective Symptom Evaluation on a scale from 1 (much improved) to 5 (much worse). Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Incidence of Treatment-Emergent Adverse Events Up to Day 252 after the last injection
Primary Change of Subjective Therapy Evaluation of Pain (HOOS Questionnaire) compared to Baseline Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Pain on a 5-point Likert scale Day 84 after last injection, Day 168 after last injection
Primary Change of Subjective Therapy Evaluation of Stiffness (HOOS Questionnaire) compared to Baseline Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Stiffness on a 5-point Likert scale Day 84 after last injection, Day 168 after last injection
Primary Change of Subjective Therapy Evaluation of Function in daily living (HOOS Questionnaire) compared to Baseline Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Function in daily living on a 5-point Likert scale Day 84 after last injection, Day 168 after last injection
Primary Change of Subjective Therapy Evaluation of Quality of Life (HOOS Questionnaire) compared to Baseline Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Quality of Life on a 5-point Likert scale Day 84 after last injection, Day 168 after last injection
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01326832 - 10 Year Clinical Evaluation of Primoris Hip Component
Completed NCT02399670 - The Influence of Global Femoral-offset Changes After Total Hip Arthroplasty N/A
Completed NCT01046019 - Measurement of Early Bone Loss Around a Total Hip Arthroplasty N/A
Completed NCT00159497 - Bone Remodeling Around HA-coated Acetabular Cups. Phase 4
Not yet recruiting NCT04570748 - Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty. N/A
Not yet recruiting NCT01079455 - Comparison of Hyaluronic Acid and Corticosteroid Intra-articular Injections for the Treatment of Osteoarthritis of the Hip Phase 3
Completed NCT00317889 - Compaction Total Hip Arthroplasty (THA) Bilateral N/A
Recruiting NCT04424628 - Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis N/A
Not yet recruiting NCT06272422 - Comparison of the Restoration of Hip Biomechanical Parameters by CT Measurement Between the 3 Surgical Techniques: RSA/Minihip/THA - Hip Replacement: 3D Planning
Completed NCT02694146 - Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis Phase 3
Completed NCT02719236 - Direct Anterior Approach Versus Direct Lateral Approach in Total Hip Arthroplasty N/A
Completed NCT05343195 - Balance and Leg Function After Hip Replacement N/A
Completed NCT01279174 - Galileo-Hip Whole Body Vibration /Conventional Physiotherapy /Coxarthrosis Phase 4
Active, not recruiting NCT00318396 - Compaction Femur Preparation for Cementless Total Hip Arthroplasty (THA) Unilateral N/A
Completed NCT02338596 - Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old Phase 4
Active, not recruiting NCT00722982 - Migration Pattern of C-stem AMT Versus Exeter in Total Hip Arthroplasty N/A
Completed NCT04903860 - Comparison of the Use of Conventional Ancillary Reaming and Single-use Ancillary Reaming Material in Total Hip Replacement N/A
Recruiting NCT04317872 - Effect of Peri-operative Glucocorticoids on Short-term Functional Outcome After THA N/A
Active, not recruiting NCT01578746 - Comparison Between Anterior and Direct Lateral Approach in Total Hip Arthroplasty Phase 4
Completed NCT00317863 - Zink and Bone Strength N/A